Reid G. Adler

Insider Reports History

Entity
Individual
Location
C/O Vistagen Therapeutics, Inc., 343 Allerton Ave., South San Francisco, CA
Signature
/s/ Cynthia Anderson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Reid G. Adler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. CHF CORP DEVEL OFF, GEN COUNS Common Stock 16.5K $48.8K $2.96 Jun 28, 2024 Direct
Vistagen Therapeutics, Inc. CHF CORP DEVEL OFF, GEN COUNS Stock Option (Right to Buy) 170K Jun 24, 2024 Direct

Insider Reports Filed by Reid G. Adler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VTGN Vistagen Therapeutics, Inc. Jun 28, 2024 1 $14.4K 4 Jul 2, 2024 CHF CORP DEVEL OFF, GEN COUNS
VTGN Vistagen Therapeutics, Inc. Jun 24, 2024 1 $0 4 Jun 26, 2024 CHF CORP DEVEL OFF, GEN COUNS
VTGN Vistagen Therapeutics, Inc. Dec 29, 2023 1 $287 4 Jan 3, 2024 CHF CORP DEVEL OFF, GEN COUNS
VTGN Vistagen Therapeutics, Inc. Jun 30, 2023 1 $265 4 Jul 5, 2023 CHIEF LEGAL OFFICER
VTGN VistaGen Therapeutics, Inc. Aug 17, 2022 1 $50.9K 4 Aug 19, 2022 CHIEF LEGAL OFFICER
VTGN VistaGen Therapeutics, Inc. May 2, 2022 1 $0 4 May 3, 2022 CHIEF LEGAL OFFICER
VTGN VistaGen Therapeutics, Inc. May 2, 2022 0 $0 3 May 3, 2022 CHIEF LEGAL OFFICER